{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T10:46:50Z","timestamp":1761821210572},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1999,6,1]],"date-time":"1999-06-01T00:00:00Z","timestamp":928195200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[1999,6]]},"DOI":"10.1007\/s11940-999-0008-6","type":"journal-article","created":{"date-parts":[[2007,6,4]],"date-time":"2007-06-04T17:27:22Z","timestamp":1180978042000},"page":"263-272","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Inflammatory myopathy"],"prefix":"10.1007","volume":"1","author":[{"given":"Frank L.","family":"Mastaglia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beverley A.","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"Zilko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"8_CR1","volume-title":"Polymyositis","author":"JN Walton","year":"1958","unstructured":"Walton JN, Adams PD: Polymyositis. London: Churchill Livingstone; 1958."},{"key":"8_CR2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJM197202172860701","volume":"286","author":"JN Whitaker","year":"1972","unstructured":"Whitaker JN, Engel WK: Vascular deposits of immunoglobulin and complement in idiopathic inflammatory myopathy. N Engl J Med 1972, 286:333\u2013338.","journal-title":"N Engl J Med"},{"key":"8_CR3","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1056\/NEJM198602063140601","volume":"314","author":"JT Kissel","year":"1986","unstructured":"Kissel JT, Mendell JR, Rammohan KW: Microvascular deposition of complement membrane attack complex in dermatomyositis. N Engl J Med 1986, 314:329\u2013334.","journal-title":"N Engl J Med"},{"key":"8_CR4","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1002\/ana.410270402","volume":"27","author":"AM Emslie-Smith","year":"1990","unstructured":"Emslie-Smith AM, Engel AG: Microvascular changes in early and advanced dermatomyositis: a quantitative study. Ann Neurol 1990, 27:343\u2013356.","journal-title":"Ann Neurol"},{"key":"8_CR5","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1016\/S0046-8177(86)80180-0","volume":"17","author":"AG Engel","year":"1986","unstructured":"Engel AG, Arahata K: Mononuclear cells in myopathies. Hum Pathol 1986, 17:704\u2013721.","journal-title":"Hum Pathol"},{"key":"8_CR6","first-page":"240","volume":"25","author":"EJ Yunis","year":"1971","unstructured":"Yunis EJ, Samaha FJ: Inclusion body myositis. Lab Invest 1971, 25:240\u2013248.","journal-title":"Lab Invest"},{"key":"8_CR7","first-page":"213","volume":"90","author":"RD Adams","year":"1965","unstructured":"Adams RD, Samaha FJ, Kakulas BA: A myopathy with cellular inclusions. Trans Am Neurol Assoc 1965, 90:213\u2013216.","journal-title":"Trans Am Neurol Assoc"},{"key":"8_CR8","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","volume":"325","author":"MC Dalakas","year":"1991","unstructured":"Dalakas MC: Polymyositis, dermatomyositis and inclusion body myositis. N Engl J Med 1991, 325:1487\u20131498.","journal-title":"N Engl J Med"},{"key":"8_CR9","volume-title":"Inclusion Body Myositis and Myopathies","author":"JR Mendell","year":"1998","unstructured":"Mendell JR: Sporadic inclusion body myositis: clinical and laboratory features and diagnostic criteria. In Inclusion Body Myositis and Myopathies. Edited by Askanas V, Serratrice G, Engel WK. Cambridge, UK: Cambridge University Press; 1998."},{"key":"8_CR10","volume-title":"Inclusion Body Myositis and Myopathies","author":"A Oldfors","year":"1998","unstructured":"Oldfors A, Moslemi A-R, Holme E, et al.: Mitochondrial alterations in sporadic inclusion body myositis. In Inclusion Body Myositis and Myopathies. Edited by Askanas V, Serratrice G, Engel WK. Cambridge, UK: Cambridge University Press; 1998."},{"key":"8_CR11","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1136\/jnnp.60.3.251","volume":"60","author":"MJ Garlepp","year":"1996","unstructured":"Garlepp MJ, Mastaglia FL: Inclusion body myositis. J Neurol Neurosurg Psychiatry 1996, 60:251\u2013255.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8_CR12","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1002\/(SICI)1097-4598(199706)20:6<651::AID-MUS1>3.0.CO;2-7","volume":"20","author":"FL Mastaglia","year":"1997","unstructured":"Mastaglia FL, Phillips BA, Zilko PJ: Treatment of inflammatory myopathy. Muscle Nerve 1997, 20:651\u2013664. A review of the treatment of inflammatory myopathies.","journal-title":"Muscle Nerve"},{"key":"8_CR13","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/S0049-0172(97)80021-2","volume":"26","author":"JM Kremer","year":"1997","unstructured":"Kremer JM: Is methotrexate oncogenic in patients with rheumatoid arthritis?\n                           Semin Arthritis Rheumatol 1997, 26:785\u2013787.","journal-title":"Semin Arthritis Rheumatol"},{"key":"8_CR14","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","volume":"329","author":"MC Dalakas","year":"1993","unstructured":"Dalakas MC, Illa I, Dambrosia JM, et al.: A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis. N Engl J Med 1993, 329:1993\u20132000.","journal-title":"N Engl J Med"},{"key":"8_CR15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1136\/jnnp.65.1.107","volume":"65","author":"FL Mastaglia","year":"1998","unstructured":"Mastaglia FL, Phillips BA, Zilko PJ: Immunoglobulin therapy in inflammatory myopathies. J Neurol Neurosurg Psychiatry 1998, 65:107\u2013110. A recent trial of intravenous immunoglobulin in various forms of inflammatory myopathy.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/0002-9343(91)90009-M","volume":"91","author":"P Cherin","year":"1991","unstructured":"Cherin P, Herson S, Wechsler B, et al.: Efficacy of intravenous gammaglobulin therapy in chronic refractory polymyositis and dermatomyositis: an open study with 20 adult patients. Am J Med 1991, 91:162\u2013168.","journal-title":"Am J Med"},{"key":"8_CR17","first-page":"1092","volume":"21","author":"P Cherin","year":"1994","unstructured":"Cherin P, Piette JC, Wechsler B, et al.: Intravenous gamma globulin as first line therapy in polymyositis and dermatomyositis: an open study in 11 adult patients. J Rheumatol 1994, 21:1092\u20131097.","journal-title":"J Rheumatol"},{"key":"8_CR18","first-page":"659","volume":"2","author":"MC Dalakas","year":"1993","unstructured":"Dalakas MC: Retroviruses and inflammatory myopathies in humans and primates. Bailliere\u2019s Clin Neurol 1993, 2:659\u2013691.","journal-title":"Bailliere\u2019s Clin Neurol"},{"key":"8_CR19","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1001\/archneur.1981.00510090038003","volume":"38","author":"PC Dau","year":"1981","unstructured":"Dau PC: Plasmapheresis in idiopathic inflammatory myopathy. Arch Neurol 1981, 38:544\u2013552.","journal-title":"Arch Neurol"},{"key":"8_CR20","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.1056\/NEJM199205213262102","volume":"326","author":"FW Miller","year":"1992","unstructured":"Miller FW, Leitman SF, Cronin ME, et al.: Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis. N Engl J Med 1992, 326:1380\u20131384.","journal-title":"N Engl J Med"},{"key":"8_CR21","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1016\/S0140-6736(89)92456-2","volume":"1","author":"J Heckmatt","year":"1989","unstructured":"Heckmatt J, Saunders C, Peters AM, et al.: Cyclosporine in juvenile dermatomyositis. Lancet 1989, 1:1063\u20131066.","journal-title":"Lancet"},{"key":"8_CR22","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0140-6736(81)91567-1","volume":"1","author":"WK Engel","year":"1981","unstructured":"Engel WK, Lighter AS, Galdi AP: Polymyositis: remarkable response to total body irradiation. Lancet 1981, 1:658.","journal-title":"Lancet"},{"key":"8_CR23","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1016\/S0140-6736(84)91019-5","volume":"1","author":"RJM Lane","year":"1984","unstructured":"Lane RJM, Hudgson P: Thymectomy in polymyositis [letter]. Lancet 1984, 1:626\u2013627.","journal-title":"Lancet"},{"key":"8_CR24","volume-title":"Inflammatory Diseases of Muscle","author":"NL Rosenberg","year":"1988","unstructured":"Rosenberg NL, Ringel SP: Adult polymyositis and dermatomyositis. In Inflammatory Diseases of Muscle. Edited by Mastaglia FL. Oxford: Blackwell Scientific Publications; 1988."},{"key":"8_CR25","first-page":"1385","volume":"19","author":"ME Sayers","year":"1992","unstructured":"Sayers ME, Chou SM, Calabrese LH: Inclusion body myositis: analysis of 32 cases. J Rheumatol 1992, 19:1385\u20131389.","journal-title":"J Rheumatol"},{"key":"8_CR26","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1097\/00005792-199307000-00002","volume":"72","author":"RL Leff","year":"1993","unstructured":"Leff RL, Miller FW, Hicks J, et al.: The treatment of inclusion body myositis: a retrospective review and a randomized, prospective trial of immunosuppressive therapy. Medicine 1993, 72:225\u2013235.","journal-title":"Medicine"},{"key":"8_CR27","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1212\/WNL.48.3.712","volume":"48","author":"MC Dalakas","year":"1997","unstructured":"Dalakas MC, Sonies B, Dambrosia J, et al.: Treatment of inclusion body myositis with IVIg: a double-blind placebo-controlled study. Neurology 1997, 48:712\u2013716. This is the only placebo-controlled trial of intravenous immunoglobulin in inclusion body myositis.","journal-title":"Neurology"},{"key":"8_CR28","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1212\/WNL.43.5.876","volume":"43","author":"SA Soueidan","year":"1993","unstructured":"Soueidan SA, Dalakas MC: Treatment of inclusion body myositis with high-dose intravenous immunoglobulin. Neurology 1993, 43:876\u2013879.","journal-title":"Neurology"},{"key":"8_CR29","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1212\/WNL.44.8.1516","volume":"4","author":"AA Amato","year":"1994","unstructured":"Amato AA, Barohn RJ, Jackson CE, et al.: Inclusion body myositis: treatment with intravenous immunoglobulin. Neurology 1994, 4:1516\u20131518.","journal-title":"Neurology"},{"key":"8_CR30","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1136\/jnnp.57.8.1008","volume":"7","author":"S Matsubara","year":"1994","unstructured":"Matsubara S, Sawa Y, Takamori M, et al.: Pulsed intravenous methylprednisolone combined with oral steroids as the initial treatment of inflammatory myopathies [letter]. J Neurol Neurosurg Psychiatry 1994, 7:1008.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8_CR31","first-page":"717","volume":"2","author":"FL Mastaglia","year":"1993","unstructured":"Mastaglia FL, Laing BA, Zilko P: Treatment of inflammatory myopathies. Bailliere\u2019s Clin Neurol 1993, 2:717\u2013740.","journal-title":"Bailliere\u2019s Clin Neurol"},{"key":"8_CR32","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1056\/NEJM199708073370603","volume":"337","author":"JD Adachi","year":"1997","unstructured":"Adachi JD, Benson WG, Brown J, et al.: Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis. N Engl J Med 1997, 337:382\u2013387.","journal-title":"N Engl J Med"},{"key":"8_CR33","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1056\/NEJM199807303390502","volume":"339","author":"KG Saag","year":"1998","unstructured":"Saag KG, Emkey R, Schnitzer TJ, et al.: Alendronate for the prevention and treatment of glucocorticoidinduced osteoporosis. N Engl J Med 1998, 339:292\u2013299.","journal-title":"N Engl J Med"},{"key":"8_CR34","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/0002-9343(93)90148-I","volume":"94","author":"MM Joffe","year":"1993","unstructured":"Joffe MM, Love LA, Leff RL, et al.: Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisolone, azathioprine and methotrexate and a comparison of their efficacy. Am J Med 1993, 94:379\u2013387.","journal-title":"Am J Med"},{"key":"8_CR35","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1002\/art.1780370304","volume":"37","author":"JM Kremer","year":"1994","unstructured":"Kremer JM, Alarcon GS, Lightfoot RW Jr., et al.: Methotrexate for rheumatoid arthritis. Arthritis Rheumatol 1994, 37:316\u2013325.","journal-title":"Arthritis Rheumatol"},{"key":"8_CR36","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-92-3-365","volume":"92","author":"TW Bunch","year":"1980","unstructured":"Bunch TW, Worthington JW, Combs JJ, et al.: Azathioprine with prednisone for polymyositis: a controlled, clinical trial. Ann Intern Med 1980, 92:365\u2013369.","journal-title":"Ann Intern Med"},{"key":"8_CR37","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1212\/WNL.46.6.1607","volume":"46","author":"C Confraveaux","year":"1996","unstructured":"Confraveaux C, Saddier P, Grimaud J, et al.: Risk of cancer from azathioprine therapy in multiple sclerosis: a case-control study. Neurology 1996, 46:1607\u20131612.","journal-title":"Neurology"},{"key":"8_CR38","doi-asserted-by":"crossref","first-page":"716","DOI":"10.7326\/0003-4819-129-9-199811010-00007","volume":"29","author":"AJ Black","year":"1998","unstructured":"Black AJ, McLeod HL, Capell HA, et al.: Thiopurine methyltransferase genotype predicts therapy-limiting severe toxicity from azathioprine. Ann Intern Med 1998, 29:716\u2013718.","journal-title":"Ann Intern Med"},{"key":"8_CR39","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1136\/ard.51.7.885","volume":"51","author":"HJ Haga","year":"1992","unstructured":"Haga HJ, D\u2019Cruz D, Asherson R, Hughes GR: Short term effects of intravenous pulses of cyclophosphamide in the treatment of connective tissue disease crises. Ann Rheumatol Dis 1992, 51:885\u2013888.","journal-title":"Ann Rheumatol Dis"},{"key":"8_CR40","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0022-5347(17)49751-5","volume":"132","author":"A Freedman","year":"1984","unstructured":"Freedman A, Ehrlich RM, Ljung BM: Prevention of cyclophosphamide cystitis with 2-mercaptoethane sodium sulfonate: a histologic study. J Urol 1984, 132:580\u2013582.","journal-title":"J Urol"},{"issue":"suppl","key":"8_CR41","first-page":"S150","volume":"7","author":"AY Mansur","year":"1998","unstructured":"Mansur AY, Topaloglu H, Jungbluth H, et al.: Cyclosporin treatment in juvenile dermatomyositis: a review of 26 cases. Muscle Nerve 1998, 7(suppl):S150.","journal-title":"Muscle Nerve"},{"key":"8_CR42","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1136\/jnnp.54.11.1007","volume":"54","author":"CJ Leuck","year":"1991","unstructured":"Leuck CJ, Trend PT, Swash M: Cyclosporin in the management of polymyositis and dermatomyositis. J Neurol Neurosurg Psychiatry 1991, 54:1007\u20131008.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"8_CR43","first-page":"381","volume":"21","author":"JM Grau","year":"1994","unstructured":"Grau JM, Herrero C, Casademont J, et al.: Cyclosporin A as first choice for dermatomyositis. J Rheumatol 1994, 21:381\u2013382.","journal-title":"J Rheumatol"},{"key":"8_CR44","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1002\/(SICI)1097-4598(199603)19:3<388::AID-MUS20>3.0.CO;2-N","volume":"19","author":"TE Bertorini","year":"1996","unstructured":"Bertorini TE, Nance AM, Horner LH, et al.: Complications of intravenous gammaglobulin in neuromuscular and other diseases. Muscle Nerve 1996, 19:388\u2013391.","journal-title":"Muscle Nerve"},{"key":"8_CR45","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1097\/00002281-199811000-00007","volume":"10","author":"JE Hicks","year":"1998","unstructured":"Hicks JE: Role of rehabilitation in the management of myopathies. Curr Opin Rheumatol 1998, 10:548\u2013555.","journal-title":"Curr Opin Rheumatol"},{"key":"8_CR46","first-page":"1340","volume":"20","author":"A Escalante","year":"1993","unstructured":"Escalante A, Miller L, Bedardmore TD: Resistive exercise in the rehabilitation of polymyositis\/dermatomyositis. J Rheumatol 1993, 20:1340\u20131344.","journal-title":"J Rheumatol"},{"key":"8_CR47","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/j.1365-2362.1985.tb00276.x","volume":"15","author":"FF Horber","year":"1985","unstructured":"Horber FF, Schiedegger JR, Grunig BE, Frey FJ: Thigh muscle mass and function in patients treated with glucocorticoids. Eur J Clin Invest 1985, 15:302\u2013307.","journal-title":"Eur J Clin Invest"},{"key":"8_CR48","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1093\/rheumatology\/37.2.196","volume":"37","author":"GR Wiesinger","year":"1998","unstructured":"Wiesinger GR, Quittan M, Aringer M, et al.: Improvement of physical fitness and muscle strength in polymyositis\/dermatomyositis patients by a training programme. Br J Rheumatol 1998, 37:196\u2013200.","journal-title":"Br J Rheumatol"},{"key":"8_CR49","doi-asserted-by":"publisher","first-page":"1242","DOI":"10.1002\/(SICI)1097-4598(199710)20:10<1242::AID-MUS6>3.0.CO;2-C","volume":"20","author":"SA Spector","year":"1997","unstructured":"Spector SA, Lemmer JT, Koffman BM, et al.: Safety and efficacy of strength training in patients with sporadic inclusion body myositis. Muscle Nerve 1997, 20:1242\u20131248.","journal-title":"Muscle Nerve"},{"key":"8_CR50","first-page":"1855","volume":"21","author":"D Zantos","year":"1994","unstructured":"Zantos D, Zhang Y, Felson D: The overall and temporal association of cancer with polymyositis and dermatomyositis. J Rheumatol 1994, 21:1855\u20131859.","journal-title":"J Rheumatol"},{"key":"8_CR51","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1017\/S031716710002953X","volume":"16","author":"MJ Danon","year":"1989","unstructured":"Danon MJ, Friedman M: Inclusion body myositis associated with progressive dysphagia: treatment with cricopharyngeal myotomy. Can J Neurol Sci 1989, 16:436\u2013438.","journal-title":"Can J Neurol Sci"},{"key":"8_CR52","first-page":"94","volume":"48","author":"A Tyndall","year":"1997","unstructured":"Tyndall A: Hematopoietic stem cell transplantation in rheumatic diseases other than systemic sclerosis and systemic lupus erythematosus. J Rheumatol 1997, 48:94\u201397.","journal-title":"J Rheumatol"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-999-0008-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11940-999-0008-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-999-0008-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-999-0008-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T11:40:24Z","timestamp":1659094824000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11940-999-0008-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,6]]},"references-count":52,"journal-issue":{"issue":"3","published-print":{"date-parts":[[1999,6]]}},"alternative-id":["8"],"URL":"https:\/\/doi.org\/10.1007\/s11940-999-0008-6","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[1999,6]]},"assertion":[{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}